Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

Cardiovascular and Metabolic Responses to a Mixed Meal
Role of Exercise Training and Body Weight on Cardiovascular and Metabolic Responses to a Mixed Meal Tolerance Test
Status: Enrolling
Updated:  9/22/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Cardiovascular and Metabolic Responses to a Mixed Meal
Role of Exercise Training and Body Weight on Cardiovascular and Metabolic Responses to a Mixed Meal Tolerance Test
Status: Enrolling
Updated: 9/22/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Physical Activity and Glycemic Control
Physical Activity and Glycemic Control
Status: Enrolling
Updated:  9/23/2015
University Of Missouri-Columbia
mi
from
Columbia, MO
Physical Activity and Glycemic Control
Physical Activity and Glycemic Control
Status: Enrolling
Updated: 9/23/2015
University Of Missouri-Columbia
mi
from
Columbia, MO
Click here to add this to my saved trials
Blood Flow Responses to an Oral Glucose Tolerance Test in Type 2 Diabetes
Acute Cardiovascular and Metabolic Effects of Exercise Training in Individuals
Status: Enrolling
Updated:  9/23/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Blood Flow Responses to an Oral Glucose Tolerance Test in Type 2 Diabetes
Acute Cardiovascular and Metabolic Effects of Exercise Training in Individuals
Status: Enrolling
Updated: 9/23/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Effect of a High-Protein Diet and/or High-Intensity Training on Metabolic Syndrome
The E-PHIT Study: Eggs, Protein, and High-Intensity Training: A Diabetes Prevention Program for Women
Status: Enrolling
Updated:  9/24/2015
Body Composition and Metabolism Lab, Ramsey Center, University of Georgia
mi
from
Athens, GA
Effect of a High-Protein Diet and/or High-Intensity Training on Metabolic Syndrome
The E-PHIT Study: Eggs, Protein, and High-Intensity Training: A Diabetes Prevention Program for Women
Status: Enrolling
Updated: 9/24/2015
Body Composition and Metabolism Lab, Ramsey Center, University of Georgia
mi
from
Athens, GA
Click here to add this to my saved trials
Exercise-Induced Epigenetic Modifications in Obese Aging Women
Status: Enrolling
Updated:  9/24/2015
Body Composition and Metabolism Lab, UGA, Ramsey Student Center
mi
from
Athens, GA
Exercise-Induced Epigenetic Modifications in Obese Aging Women
Status: Enrolling
Updated: 9/24/2015
Body Composition and Metabolism Lab, UGA, Ramsey Student Center
mi
from
Athens, GA
Click here to add this to my saved trials
Rosiglitazone to Treat Patients With Heart Failure and Glucose Intolerance or Type II Diabetes
Attenuating Insulin Resistance as a Therapeutic Target in the Management of Heart Failure
Status: Enrolling
Updated:  9/26/2015
Suburban Hospital
mi
from
Bethesda, MD
Rosiglitazone to Treat Patients With Heart Failure and Glucose Intolerance or Type II Diabetes
Attenuating Insulin Resistance as a Therapeutic Target in the Management of Heart Failure
Status: Enrolling
Updated: 9/26/2015
Suburban Hospital
mi
from
Bethesda, MD
Click here to add this to my saved trials
Rosiglitazone to Treat Patients With Heart Failure and Glucose Intolerance or Type II Diabetes
Attenuating Insulin Resistance as a Therapeutic Target in the Management of Heart Failure
Status: Enrolling
Updated:  9/26/2015
National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike
mi
from
Bethesda, MD
Rosiglitazone to Treat Patients With Heart Failure and Glucose Intolerance or Type II Diabetes
Attenuating Insulin Resistance as a Therapeutic Target in the Management of Heart Failure
Status: Enrolling
Updated: 9/26/2015
National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Rosiglitazone to Reverse Metabolic Defects in Diabetes
Evaluation of Rosiglitazone in Reversing Metabolic Defects of Pre-Diabetes and Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Rosiglitazone to Reverse Metabolic Defects in Diabetes
Evaluation of Rosiglitazone in Reversing Metabolic Defects of Pre-Diabetes and Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Rosiglitazone to Reverse Metabolic Defects in Diabetes
Evaluation of Rosiglitazone in Reversing Metabolic Defects of Pre-Diabetes and Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  9/26/2015
Medical College of Virginia
mi
from
Richmond, VA
Rosiglitazone to Reverse Metabolic Defects in Diabetes
Evaluation of Rosiglitazone in Reversing Metabolic Defects of Pre-Diabetes and Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 9/26/2015
Medical College of Virginia
mi
from
Richmond, VA
Click here to add this to my saved trials
Salivary Proteins in Disease and Health
Salivary Proteomics in Disease and Health
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Salivary Proteins in Disease and Health
Salivary Proteomics in Disease and Health
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Cinacalcet to Treat Familial Primary Hyperparathyroidism
Cinacalcet Actions in Familial Primary Hyperparathyroidism
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Cinacalcet to Treat Familial Primary Hyperparathyroidism
Cinacalcet Actions in Familial Primary Hyperparathyroidism
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Confirmation of Systemic Autoimmune Diseases in the Agricultural Health Study
Confirmation of Systemic Autoimmune Diseases in the Agricultural Health Study
Status: Enrolling
Updated:  9/26/2015
University of Iowa
mi
from
Iowa City, IA
Confirmation of Systemic Autoimmune Diseases in the Agricultural Health Study
Confirmation of Systemic Autoimmune Diseases in the Agricultural Health Study
Status: Enrolling
Updated: 9/26/2015
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Confirmation of Systemic Autoimmune Diseases in the Agricultural Health Study
Confirmation of Systemic Autoimmune Diseases in the Agricultural Health Study
Status: Enrolling
Updated:  9/26/2015
Battelle Centers for Public Health Research and Evaluation
mi
from
Durham, NC
Confirmation of Systemic Autoimmune Diseases in the Agricultural Health Study
Confirmation of Systemic Autoimmune Diseases in the Agricultural Health Study
Status: Enrolling
Updated: 9/26/2015
Battelle Centers for Public Health Research and Evaluation
mi
from
Durham, NC
Click here to add this to my saved trials
Confirmation of Systemic Autoimmune Diseases in the Agricultural Health Study
Confirmation of Systemic Autoimmune Diseases in the Agricultural Health Study
Status: Enrolling
Updated:  9/26/2015
NIEHS, Research Triangle Park
mi
from
Research Triangle Park, NC
Confirmation of Systemic Autoimmune Diseases in the Agricultural Health Study
Confirmation of Systemic Autoimmune Diseases in the Agricultural Health Study
Status: Enrolling
Updated: 9/26/2015
NIEHS, Research Triangle Park
mi
from
Research Triangle Park, NC
Click here to add this to my saved trials
Physiologic Regulation of FGF-23
Physiologic Regulation of FGF-23
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Physiologic Regulation of FGF-23
Physiologic Regulation of FGF-23
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Eye and Immunogenetic Features of Sarcoidosis
Ocular and Immuno-Genetic Manifestations of Sarcoidosis
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Eye and Immunogenetic Features of Sarcoidosis
Ocular and Immuno-Genetic Manifestations of Sarcoidosis
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1500
Status: Enrolling
Updated:  9/28/2015
Clinical Research Facility
mi
from
Daytona Beach, FL
Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1500
Status: Enrolling
Updated: 9/28/2015
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1500
Status: Enrolling
Updated:  9/28/2015
Clinical Research Facility
mi
from
Evansville, IN
Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1500
Status: Enrolling
Updated: 9/28/2015
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1500
Status: Enrolling
Updated:  9/28/2015
Clinical Research Facility
mi
from
Dallas, TX
Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1500
Status: Enrolling
Updated: 9/28/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1500
Status: Enrolling
Updated:  9/28/2015
Clinical Research Facility
mi
from
San Antonio, TX
Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1500
Status: Enrolling
Updated: 9/28/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer
Phase II Study of Sunitinib in Iodine Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of Thyroid With Functional Imaging Correlation
Status: Enrolling
Updated:  9/28/2015
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
mi
from
Seattle, WA
Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer
Phase II Study of Sunitinib in Iodine Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of Thyroid With Functional Imaging Correlation
Status: Enrolling
Updated: 9/28/2015
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Translating a Heart Disease Lifestyle Intervention Into the Community
Translating a Heart Disease Lifestyle Intervention Into the Community
Status: Enrolling
Updated:  10/1/2015
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Translating a Heart Disease Lifestyle Intervention Into the Community
Translating a Heart Disease Lifestyle Intervention Into the Community
Status: Enrolling
Updated: 10/1/2015
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Translating a Heart Disease Lifestyle Intervention Into the Community
Translating a Heart Disease Lifestyle Intervention Into the Community
Status: Enrolling
Updated:  10/1/2015
Metropolitan Asian Family Services
mi
from
Chicago, IL
Translating a Heart Disease Lifestyle Intervention Into the Community
Translating a Heart Disease Lifestyle Intervention Into the Community
Status: Enrolling
Updated: 10/1/2015
Metropolitan Asian Family Services
mi
from
Chicago, IL
Click here to add this to my saved trials
Validation of an RLIP76 Assay in Humans
Validation of RLIP76 Assay and Exploratory Study of RLIP76 Correlation Among Patients With Type 2 Diabetes and Metabolic Syndrome
Status: Enrolling
Updated:  10/1/2015
City of Hope Medical Center
mi
from
Duarte, CA
Validation of an RLIP76 Assay in Humans
Validation of RLIP76 Assay and Exploratory Study of RLIP76 Correlation Among Patients With Type 2 Diabetes and Metabolic Syndrome
Status: Enrolling
Updated: 10/1/2015
City of Hope Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Diet X Genotype Study
Do Genotype Patterns Predict Weight Loss Success for Low Carb vs. Low Fat Diets?
Status: Enrolling
Updated:  10/1/2015
Stanford University School of Medicine
mi
from
Stanford, CA
Diet X Genotype Study
Do Genotype Patterns Predict Weight Loss Success for Low Carb vs. Low Fat Diets?
Status: Enrolling
Updated: 10/1/2015
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Duloxetine for Chronic Depression: a Double-blind Study
Duloxetine for Chronic Depression: a Double-blind Study
Status: Enrolling
Updated:  10/5/2015
New York State Psychiatric Institute
mi
from
New York, NY
Duloxetine for Chronic Depression: a Double-blind Study
Duloxetine for Chronic Depression: a Double-blind Study
Status: Enrolling
Updated: 10/5/2015
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
An Initial Study of Lithium in Patients With Medullary Thyroid Cancer
An Initial Study of Lithium in Patients With Medullary Thyroid Cancer
Status: Enrolling
Updated:  10/6/2015
Uniersity of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
An Initial Study of Lithium in Patients With Medullary Thyroid Cancer
An Initial Study of Lithium in Patients With Medullary Thyroid Cancer
Status: Enrolling
Updated: 10/6/2015
Uniersity of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Treatment of Vitamin D Insufficiency
Treatment of Vitamin D Insufficiency
Status: Enrolling
Updated:  10/6/2015
University of Wisconsin School of Medicine and Public Health
mi
from
Madison, WI
Treatment of Vitamin D Insufficiency
Treatment of Vitamin D Insufficiency
Status: Enrolling
Updated: 10/6/2015
University of Wisconsin School of Medicine and Public Health
mi
from
Madison, WI
Click here to add this to my saved trials
Study of Dietary Additive Phosphorus on Proteinuria and Fibroblast Growth Factor-23
Randomized Cross-over Study Examining the Effects of Phosphorus Additives on Urinary Albumin Excretion and Fibroblast Growth Factor-23
Status: Enrolling
Updated:  10/8/2015
Prohealth Clinical Research Unit
mi
from
Baltimore, MD
Study of Dietary Additive Phosphorus on Proteinuria and Fibroblast Growth Factor-23
Randomized Cross-over Study Examining the Effects of Phosphorus Additives on Urinary Albumin Excretion and Fibroblast Growth Factor-23
Status: Enrolling
Updated: 10/8/2015
Prohealth Clinical Research Unit
mi
from
Baltimore, MD
Click here to add this to my saved trials
How Does Magnesium Status Influence Calcium Homeostasis?
How Does Magnesium Status Influence Calcium Homeostasis?
Status: Enrolling
Updated:  10/9/2015
University of Wisconsin-Madison Hospital, Clinical Research Unit, Osteoporosis Research Center
mi
from
Madison, WI
How Does Magnesium Status Influence Calcium Homeostasis?
How Does Magnesium Status Influence Calcium Homeostasis?
Status: Enrolling
Updated: 10/9/2015
University of Wisconsin-Madison Hospital, Clinical Research Unit, Osteoporosis Research Center
mi
from
Madison, WI
Click here to add this to my saved trials
Predictors of Response to Fenofibrate
Pretreatment Genotyping at APOA5 and GCKR Loci and Response to Fenofibrate Therapy
Status: Enrolling
Updated:  10/11/2015
UAB Kirklin Clinic
mi
from
Birmingham, AL
Predictors of Response to Fenofibrate
Pretreatment Genotyping at APOA5 and GCKR Loci and Response to Fenofibrate Therapy
Status: Enrolling
Updated: 10/11/2015
UAB Kirklin Clinic
mi
from
Birmingham, AL
Click here to add this to my saved trials
Investigator Initiated Study of the Effects of Androgen Therapy on Carbohydrate and Lipid Metabolism In Elderly Men
Status: Enrolling
Updated:  10/12/2015
LAC-USC Medical Center GCRC
mi
from
Los Angeles, CA
Investigator Initiated Study of the Effects of Androgen Therapy on Carbohydrate and Lipid Metabolism In Elderly Men
Status: Enrolling
Updated: 10/12/2015
LAC-USC Medical Center GCRC
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Trial of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
A Randomized, Double-blind, Placebo-controlled Trial to Assess Efficacy and Tolerability of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
Status: Enrolling
Updated:  10/12/2015
Radiant Research Inc.
mi
from
Chicago, IL
Trial of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
A Randomized, Double-blind, Placebo-controlled Trial to Assess Efficacy and Tolerability of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
Status: Enrolling
Updated: 10/12/2015
Radiant Research Inc.
mi
from
Chicago, IL
Click here to add this to my saved trials
Trial of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
A Randomized, Double-blind, Placebo-controlled Trial to Assess Efficacy and Tolerability of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
Status: Enrolling
Updated:  10/12/2015
Central Kentucky Research Associates, Inc.
mi
from
Lexington, KY
Trial of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
A Randomized, Double-blind, Placebo-controlled Trial to Assess Efficacy and Tolerability of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
Status: Enrolling
Updated: 10/12/2015
Central Kentucky Research Associates, Inc.
mi
from
Lexington, KY
Click here to add this to my saved trials
Trial of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
A Randomized, Double-blind, Placebo-controlled Trial to Assess Efficacy and Tolerability of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
Status: Enrolling
Updated:  10/12/2015
QUEST Research Institute
mi
from
Bingham Farms, MI
Trial of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
A Randomized, Double-blind, Placebo-controlled Trial to Assess Efficacy and Tolerability of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
Status: Enrolling
Updated: 10/12/2015
QUEST Research Institute
mi
from
Bingham Farms, MI
Click here to add this to my saved trials
Trial of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
A Randomized, Double-blind, Placebo-controlled Trial to Assess Efficacy and Tolerability of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
Status: Enrolling
Updated:  10/12/2015
Radiant Research, Inc.
mi
from
Cincinnati, OH
Trial of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
A Randomized, Double-blind, Placebo-controlled Trial to Assess Efficacy and Tolerability of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
Status: Enrolling
Updated: 10/12/2015
Radiant Research, Inc.
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Trial of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
A Randomized, Double-blind, Placebo-controlled Trial to Assess Efficacy and Tolerability of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
Status: Enrolling
Updated:  10/12/2015
Providence Health Partners-Center for Clinical Research
mi
from
Dayton, OH
Trial of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
A Randomized, Double-blind, Placebo-controlled Trial to Assess Efficacy and Tolerability of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
Status: Enrolling
Updated: 10/12/2015
Providence Health Partners-Center for Clinical Research
mi
from
Dayton, OH
Click here to add this to my saved trials
Trial of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
A Randomized, Double-blind, Placebo-controlled Trial to Assess Efficacy and Tolerability of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
Status: Enrolling
Updated:  10/12/2015
Mountain View Clinical Research
mi
from
Greer, SC
Trial of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
A Randomized, Double-blind, Placebo-controlled Trial to Assess Efficacy and Tolerability of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
Status: Enrolling
Updated: 10/12/2015
Mountain View Clinical Research
mi
from
Greer, SC
Click here to add this to my saved trials
Escitalopram in the Treatment of Dysthymic Disorder, Double Blind
Double-Blind Placebo-Controlled Study of Escitalopram in the Treatment of Dysthymic Disorder
Status: Enrolling
Updated:  10/13/2015
Mood Disorders Research Program, St. Luke's-Roosevelt Hospital Center
mi
from
New York, NY
Escitalopram in the Treatment of Dysthymic Disorder, Double Blind
Double-Blind Placebo-Controlled Study of Escitalopram in the Treatment of Dysthymic Disorder
Status: Enrolling
Updated: 10/13/2015
Mood Disorders Research Program, St. Luke's-Roosevelt Hospital Center
mi
from
New York, NY
Click here to add this to my saved trials
Effect of Cabergoline on Weight and Glucose Tolerance
Randomized Controlled Pilot Study of the Effect of Cabergoline on Body Weight and Glucose Tolerance in Healthy Obese Adults
Status: Enrolling
Updated:  10/13/2015
Columbia University
mi
from
New York, NY
Effect of Cabergoline on Weight and Glucose Tolerance
Randomized Controlled Pilot Study of the Effect of Cabergoline on Body Weight and Glucose Tolerance in Healthy Obese Adults
Status: Enrolling
Updated: 10/13/2015
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Soybean Oil Trial of cArdiovascular Risk
The Effect of High-Oleic Soybean Oil on Biomarkers of Risk for Metabolic Syndrome
Status: Enrolling
Updated:  10/14/2015
USDA-ARS, Beltsville Human Nutrition Research Center
mi
from
Beltsville, MD
Soybean Oil Trial of cArdiovascular Risk
The Effect of High-Oleic Soybean Oil on Biomarkers of Risk for Metabolic Syndrome
Status: Enrolling
Updated: 10/14/2015
USDA-ARS, Beltsville Human Nutrition Research Center
mi
from
Beltsville, MD
Click here to add this to my saved trials
Regulation of Branched-chain Amino Acid Metabolism in Pre-Diabetes
Regulation of Branched-chain Amino Acid Metabolism in Pre-Diabetes: Responses to Exercise Training and Gastric Bypass Surgery
Status: Enrolling
Updated:  10/15/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Regulation of Branched-chain Amino Acid Metabolism in Pre-Diabetes
Regulation of Branched-chain Amino Acid Metabolism in Pre-Diabetes: Responses to Exercise Training and Gastric Bypass Surgery
Status: Enrolling
Updated: 10/15/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Treatment of Insomnia and Glucose Metabolism
Double-blind Placebo-controlled Study of the Effects of Eszopiclone on Glucose Tolerance, Insulin Secretion, and Insulin Action in Adults With Chronic Insomnia
Status: Enrolling
Updated:  10/15/2015
University of Chicago
mi
from
Chicago, IL
Treatment of Insomnia and Glucose Metabolism
Double-blind Placebo-controlled Study of the Effects of Eszopiclone on Glucose Tolerance, Insulin Secretion, and Insulin Action in Adults With Chronic Insomnia
Status: Enrolling
Updated: 10/15/2015
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Eliglustat Tartrate (Genz-112638) in Type 1 Gaucher Patients
A Phase 2, Open-Label, Multi-Center Study Evaluating the Efficacy, Safety and Pharmacokinetics of Genz-112638 in Gaucher Type 1 Patients
Status: Enrolling
Updated:  10/16/2015
New York University
mi
from
New York, NY
A Study of the Efficacy and Safety of Eliglustat Tartrate (Genz-112638) in Type 1 Gaucher Patients
A Phase 2, Open-Label, Multi-Center Study Evaluating the Efficacy, Safety and Pharmacokinetics of Genz-112638 in Gaucher Type 1 Patients
Status: Enrolling
Updated: 10/16/2015
New York University
mi
from
New York, NY
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Eliglustat Tartrate (Genz-112638) in Type 1 Gaucher Patients
A Phase 2, Open-Label, Multi-Center Study Evaluating the Efficacy, Safety and Pharmacokinetics of Genz-112638 in Gaucher Type 1 Patients
Status: Enrolling
Updated:  10/16/2015
Clinical Research Facility
mi
from
New York, NY
A Study of the Efficacy and Safety of Eliglustat Tartrate (Genz-112638) in Type 1 Gaucher Patients
A Phase 2, Open-Label, Multi-Center Study Evaluating the Efficacy, Safety and Pharmacokinetics of Genz-112638 in Gaucher Type 1 Patients
Status: Enrolling
Updated: 10/16/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Eliglustat Tartrate (Genz-112638) in Type 1 Gaucher Patients
A Phase 2, Open-Label, Multi-Center Study Evaluating the Efficacy, Safety and Pharmacokinetics of Genz-112638 in Gaucher Type 1 Patients
Status: Enrolling
Updated:  10/16/2015
Aprillus Asistencia e Investigación
mi
from
Buenos Aires,
A Study of the Efficacy and Safety of Eliglustat Tartrate (Genz-112638) in Type 1 Gaucher Patients
A Phase 2, Open-Label, Multi-Center Study Evaluating the Efficacy, Safety and Pharmacokinetics of Genz-112638 in Gaucher Type 1 Patients
Status: Enrolling
Updated: 10/16/2015
Aprillus Asistencia e Investigación
mi
from
Buenos Aires,
Click here to add this to my saved trials
Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome
An Open-Label Proof of Concept Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome
Status: Enrolling
Updated:  10/20/2015
Hospital for Special Surgery
mi
from
New York, NY
Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome
An Open-Label Proof of Concept Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome
Status: Enrolling
Updated: 10/20/2015
Hospital for Special Surgery
mi
from
New York, NY
Click here to add this to my saved trials
Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome
An Open-Label Proof of Concept Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome
Status: Enrolling
Updated:  10/20/2015
University of Texas Medical Branch
mi
from
Galveston, TX
Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome
An Open-Label Proof of Concept Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome
Status: Enrolling
Updated: 10/20/2015
University of Texas Medical Branch
mi
from
Galveston, TX
Click here to add this to my saved trials
Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome
An Open-Label Proof of Concept Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome
Status: Enrolling
Updated:  10/20/2015
O&O Alpan
mi
from
Fairfax, VA
Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome
An Open-Label Proof of Concept Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome
Status: Enrolling
Updated: 10/20/2015
O&O Alpan
mi
from
Fairfax, VA
Click here to add this to my saved trials
Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome
An Open-Label Proof of Concept Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome
Status: Enrolling
Updated:  10/20/2015
Hospital das Clínicas da Faculdade de Medicina da USP
mi
from
São Paulo,
Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome
An Open-Label Proof of Concept Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome
Status: Enrolling
Updated: 10/20/2015
Hospital das Clínicas da Faculdade de Medicina da USP
mi
from
São Paulo,
Click here to add this to my saved trials